Viscogliosi Brothers Acquisition Corp, trading under the ticker VBOC, is a blank-check company sponsored by Viscogliosi Brothers, LLC, a firm whose principals carry deep operating experience in orthopedic, spine, and musculoskeletal medical technology. The SPAC completed its IPO in 2021 with a stated focus on healthcare and medical device targets. On July 6, 2023, the company filed an 8-K with the SEC under accession number 0001104659-23-078537, signaling a material corporate development during its search and extension period. VBOC reflects the broader trend of sector-specialist sponsors bringing domain expertise to SPAC formation in the life sciences and medtech space. Sign up at SpacDesk for complete filing history, timeline data, and deal analytics on VBOC and hundreds of other active SPACs.